HFA Premium Access

Cardiac contractility modulation improves peak VO2, long-term survival and hospitalisations in heart failure with reduced ejection fraction; evidence from FIX-5C and the EU registry

Congress Presentation

About the speaker

Professor Gerd Hasenfuss

Georg-August University, Goettingen (Germany)
22 presentations
0 follower

11 more presentations in this session

Upgrades from a previous device compared to de novo CRT implantation in the CRT Survey II: a European Society of Cardiology survey of cardiac resynchronization therapy in 11.088 patients

Speaker: Professor C. Linde (Stockholm, SE)


Discussion - CRT Survey II


Long-term outcome in the pivotal MOMENTUM 3 trial: medical resource use and cost implications

Speaker: Professor M. Mehra (Boston, US)


Discussion - MOMENTUM 3


Discussion - FIX-5C and the EU registry


Access the full session

Late breaking trial III - Innovative and device therapy

Speakers: Professor G. Hasenfuss, Professor C. Linde, Professor M. Mehra

About the event


Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb